 | • レポートコード：QY20ST-05336 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：化学・材料 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のレボドパ市場について種類別（0.98、0.99、その他）、用途別（製薬、栄養補助食品）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・レボドパ市場の概要 ・世界の主要地域別レボドパ市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のレボドパ市場規模2015-2026：種類別（0.98、0.99、その他） ・世界のレボドパ市場規模2015-2026：用途別（製薬、栄養補助食品） ・レボドパの北米市場規模2015-2020 ・レボドパのヨーロッパ市場規模2015-2020 ・レボドパの中国市場規模2015-2020 ・レボドパの日本市場規模2015-2020 ・レボドパの東南アジア市場規模2015-2020 ・レボドパのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・レボドパの製造コスト分析 ・販売チャネル、流通業者、顧客 ・レボドパの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Levodopa Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Levodopa market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Levodopa is a naturally occurring dietary supplement and psychoactive drug found in certain kinds of food and herbs, and is synthesized from the amino acid L-tyrosine in the mammalian body and brain.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Levodopa market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Levodopa industry.
Based on our recent survey, we have several different scenarios about the Levodopa YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Levodopa will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Levodopa market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Levodopa market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Levodopa market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Levodopa market. The report also includes nautical information, where it shows Levodopa market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Levodopa market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Levodopa market.
Aside from its natural and essential biological role, L-DOPA is also used in the clinical treatment of Parkinson’s disease and dopamine-responsive dystonia. When used in a pharmaceutical context, the INN designation ‘levodopa’ is normally used.
Geographical Analysis:
Based on region, the global Levodopa market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Levodopa market are
Xi’an Lyphar Biotech
Hindustan Herbals
Xi’an ZB Biotech
Xi’an Arisun ChemPharm
Hunan Nutramax
…
Segment by Type
0.98
0.99
Others
Segment by Application
Pharmaceuticals Industry
Dietary Supplements
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Levodopa market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Levodopa market.
• The market share of the global Levodopa market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Levodopa market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Levodopa market.
1 Levodopa Market Overview
1.1 Levodopa Product Scope
1.2 Levodopa Segment by Type
1.2.1 Global Levodopa Sales by Type (2020-2026)
1.2.2 0.98
1.2.3 0.99
1.2.4 Others
1.3 Levodopa Segment by Application
1.3.1 Global Levodopa Sales Comparison by Application (2020-2026)
1.3.2 Pharmaceuticals Industry
1.3.3 Dietary Supplements
1.4 Levodopa Market Estimates and Forecasts (2015-2026)
1.4.1 Global Levodopa Sales Growth Rate (2015-2026)
1.4.2 Global Levodopa Revenue and Growth Rate (2015-2026)
1.4.3 Global Levodopa Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Levodopa Industry Impact
1.5.1 How the Covid-19 is Affecting the Levodopa Industry
1.5.1.1 Levodopa Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Levodopa Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Levodopa Players to Combat Covid-19 Impact
2 Levodopa Estimate and Forecast by Region
2.1 Global Levodopa Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Levodopa Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Levodopa Sales Market Share by Region (2015-2020)
2.2.2 Global Levodopa Revenue Market Share by Region (2015-2020)
2.3 Global Levodopa Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Levodopa Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Levodopa Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Levodopa Estimates and Projections (2015-2026)
2.4.2 Europe Levodopa Estimates and Projections (2015-2026)
2.4.3 China Levodopa Estimates and Projections (2015-2026)
2.4.4 Japan Levodopa Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Levodopa Estimates and Projections (2015-2026)
2.4.6 India Levodopa Estimates and Projections (2015-2026)
3 Global Levodopa Competition Landscape by Players
3.1 Global Top Levodopa Players by Sales (2015-2020)
3.2 Global Top Levodopa Players by Revenue (2015-2020)
3.3 Global Levodopa Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Levodopa as of 2019)
3.4 Global Levodopa Average Price by Company (2015-2020)
3.5 Manufacturers Levodopa Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Levodopa Players (Opinion Leaders)
4 Global Levodopa Market Size by Type
4.1 Global Levodopa Historic Market Review by Type (2015-2020)
4.1.1 Global Levodopa Sales Market Share by Type (2015-2020)
4.1.2 Global Levodopa Revenue Market Share by Type (2015-2020)
4.1.3 Global Levodopa Price by Type (2014-2020)
4.2 Global Levodopa Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Levodopa Sales Forecast by Type (2021-2026)
4.2.2 Global Levodopa Revenue Forecast by Type (2021-2026)
4.2.3 Global Levodopa Price Forecast by Type (2021-2026)
5 Global Levodopa Market Size by Application
5.1 Global Levodopa Historic Market Review by Application (2015-2020)
5.1.1 Global Levodopa Sales Market Share by Application (2015-2020)
5.1.2 Global Levodopa Revenue Market Share by Application (2015-2020)
5.1.3 Global Levodopa Price by Application (2015-2020)
5.2 Global Levodopa Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Levodopa Sales Forecast by Application (2021-2026)
5.2.2 Global Levodopa Revenue Forecast by Application (2021-2026)
5.2.3 Global Levodopa Price Forecast by Application (2021-2026)
3 North America Levodopa Market Facts & Figures
3.2 North America Levodopa Sales Market Share by Company (2015-2020)
3.3 North America Levodopa Sales Market Share by Type (2015-2020)
3.4 North America Levodopa Sales Market Share by Application (2015-2020)
4 Europe Levodopa Market Facts & Figures
4.2 Europe Levodopa Sales Market Share by Company (2015-2020)
4.3 Europe Levodopa Sales Market Share by Type (2015-2020)
4.4 Europe Levodopa Sales Market Share by Application (2015-2020)
5 China Levodopa Market Facts & Figures
5.2 China Levodopa Sales Market Share by Company (2015-2020)
5.3 China Levodopa Sales Market Share by Type (2015-2020)
5.4 China Levodopa Sales Market Share by Application (2015-2020)
6 Japan Levodopa Market Facts & Figures
6.2 Japan Levodopa Sales Market Share by Company (2015-2020)
6.3 Japan Levodopa Sales Market Share by Type (2015-2020)
6.4 Japan Levodopa Sales Market Share by Application (2015-2020)
7 Southeast Asia Levodopa Market Facts & Figures
7.2 Southeast Asia Levodopa Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Levodopa Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Levodopa Sales Market Share by Application (2015-2020)
8 India Levodopa Market Facts & Figures
8.2 India Levodopa Sales Market Share by Company (2015-2020)
8.3 India Levodopa Sales Market Share by Type (2015-2020)
8.4 India Levodopa Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Levodopa Business
12.1 Xi’an Lyphar Biotech
12.1.1 Xi’an Lyphar Biotech Levodopa Corporation Information
12.1.2 Xi’an Lyphar Biotech Levodopa Business Overview and Total Revenue
12.1.3 Xi’an Lyphar Biotech Levodopa Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Xi’an Lyphar Biotech Levodopa Products Offered
12.1.5 Xi’an Lyphar Biotech Recent Development
12.2 Hindustan Herbals
12.2.1 Hindustan Herbals Levodopa Corporation Information
12.2.2 Hindustan Herbals Levodopa Business Overview and Total Revenue
12.2.3 Hindustan Herbals Levodopa Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Hindustan Herbals Levodopa Products Offered
12.2.5 Hindustan Herbals Recent Development
12.3 Xi’an ZB Biotech
12.3.1 Xi’an ZB Biotech Levodopa Corporation Information
12.3.2 Xi’an ZB Biotech Levodopa Business Overview and Total Revenue
12.3.3 Xi’an ZB Biotech Levodopa Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Xi’an ZB Biotech Levodopa Products Offered
12.3.5 Xi’an ZB Biotech Recent Development
12.4 Xi’an Arisun ChemPharm
12.4.1 Xi’an Arisun ChemPharm Levodopa Corporation Information
12.4.2 Xi’an Arisun ChemPharm Levodopa Business Overview and Total Revenue
12.4.3 Xi’an Arisun ChemPharm Levodopa Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Xi’an Arisun ChemPharm Levodopa Products Offered
12.4.5 Xi’an Arisun ChemPharm Recent Development
12.5 Hunan Nutramax
12.5.1 Hunan Nutramax Levodopa Corporation Information
12.5.2 Hunan Nutramax Levodopa Business Overview and Total Revenue
12.5.3 Hunan Nutramax Levodopa Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Hunan Nutramax Levodopa Products Offered
12.5.5 Hunan Nutramax Recent Development
…
13 Levodopa Manufacturing Cost Analysis
13.1 Levodopa Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Levodopa
13.4 Levodopa Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Levodopa Distributors List
14.3 Levodopa Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Levodopa Sales (MT) Growth Rate by Type (2020-2026)
Table 2. Global Levodopa Sales (MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Levodopa Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Levodopa Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Levodopa Players to Combat Covid-19 Impact
Table 8. Global Market Levodopa Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Levodopa Sales (MT) by Region (2015-2020)
Table 10. Global Levodopa Sales Market Share by Region (2015-2020)
Table 11. Global Levodopa Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Levodopa Revenue Share by Region (2015-2020)
Table 13. Global Levodopa Sales (MT) Forecast by Region (2021-2026)
Table 14. Global Levodopa Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Levodopa Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Levodopa Revenue Share Forecast by Region (2021-2026)
Table 17. Global Levodopa (MT) of Key Companies (2015-2020)
Table 18. Global Levodopa Sales Share by Company (2015-2020)
Table 19. Global Levodopa Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Levodopa Revenue Share by Company (2015-2020)
Table 21. Global Levodopa by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Levodopa as of 2019)
Table 22. Global Levodopa Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Levodopa Manufacturing Sites and Area Served
Table 24. Manufacturers Levodopa Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Levodopa Players
Table 27. Global Levodopa Sales (MT) by Type (2015-2020)
Table 28. Global Levodopa Sales Share by Type (2015-2020)
Table 29. Global Levodopa Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Levodopa Price (MT) by Type (2015-2020)
Table 31. Global Levodopa Sales Share by Type (2021-2026)
Table 32. Global Levodopa Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Levodopa Revenue Share by Type (2021-2026)
Table 34. Global Levodopa Price (MT) by Type (2021-2026)
Table 35. Global Levodopa Sales (MT) by Application (2015-2020)
Table 36. Global Levodopa Sales Share by Application (2015-2020)
Table 37. Global Levodopa Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Levodopa Price (MT) by Application (2015-2020)
Table 39. Global Levodopa Sales (MT) by Application (2021-2026)
Table 40. Global Levodopa Sales Share by Application (2021-2026)
Table 41. Global Levodopa Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Levodopa Revenue Share by Application (2021-2026)
Table 43. Global Levodopa Price (MT) by Application (2021-2026)
Table 44. United States Levodopa Sales (MT) by Company (2015-2020)
Table 45. United States Levodopa Sales Market Share by Company (2015-2020)
Table 46. United States Levodopa Sales (MT) by Type (2015-2020)
Table 47. United States Levodopa Sales Market Share by Type (2015-2020)
Table 48. United States Levodopa Sales (MT) by Application (2015-2020)
Table 49. United States Levodopa Sales Market Share by Application (2015-2020)
Table 50. Europe Levodopa Sales (MT) by Company (2015-2020)
Table 51. Europe Levodopa Sales Market Share by Company (2015-2020)
Table 52. Europe Levodopa Sales (MT) by Type (2015-2020)
Table 53. Europe Levodopa Sales Market Share by Type (2015-2020)
Table 54. Europe Levodopa Sales (MT) by Application (2015-2020)
Table 55. Europe Levodopa Sales Market Share by Type (2015-2020)
Table 56. China Levodopa Sales (MT) by Company (2015-2020)
Table 57. China Levodopa Sales Market Share by Company (2015-2020)
Table 58. China Levodopa Sales (MT) by Type (2015-2020)
Table 59. China Levodopa Sales Market Share by Type (2015-2020)
Table 60. China Levodopa Sales (MT) by Application (2015-2020)
Table 61. China Levodopa Sales Market Share by Application (2015-2020)
Table 62. Japan Levodopa Sales (MT) by Company (2015-2020)
Table 63. Japan Levodopa Sales Market Share by Company (2015-2020)
Table 64. Japan Levodopa Sales (MT) by Type (2015-2020)
Table 65. Japan Levodopa Sales Market Share by Type (2015-2020)
Table 66. Japan Levodopa Sales (MT) by Application (2015-2020)
Table 67. Japan Levodopa Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Levodopa Sales (MT) by Company (2015-2020)
Table 69. Southeast Asia Levodopa Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Levodopa Sales (MT) by Type (2015-2020)
Table 71. Southeast Asia Levodopa Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Levodopa Sales (MT) by Type (2015-2020)
Table 73. Southeast Asia Levodopa Sales Market Share by Application (2015-2020)
Table 74. India Levodopa Sales (MT) by Company (2015-2020)
Table 75. India Levodopa Sales Market Share by Company (2015-2020)
Table 76. India Levodopa Sales (MT) by Type (2015-2020)
Table 77. India Levodopa Sales Market Share by Type (2015-2020)
Table 78. India Levodopa Sales (MT) by Application (2015-2020)
Table 79. India Levodopa Sales Market Share by Application (2015-2020)
Table 80. Xi'an Lyphar Biotech Corporation Information
Table 81. Xi'an Lyphar Biotech Description and Business Overview
Table 82. Xi'an Lyphar Biotech Levodopa Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Xi'an Lyphar Biotech Levodopa Product
Table 84. Xi'an Lyphar Biotech Recent Development
Table 85. Hindustan Herbals Corporation Information
Table 86. Hindustan Herbals Description and Business Overview
Table 87. Hindustan Herbals Levodopa Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Hindustan Herbals Levodopa Product
Table 89. Hindustan Herbals Recent Development
Table 90. Xi'an ZB Biotech Corporation Information
Table 91. Xi'an ZB Biotech Description and Business Overview
Table 92. Xi'an ZB Biotech Levodopa Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Xi'an ZB Biotech Levodopa Product
Table 94. Xi'an ZB Biotech Recent Development
Table 95. Xi'an Arisun ChemPharm Corporation Information
Table 96. Xi'an Arisun ChemPharm Description and Business Overview
Table 97. Xi'an Arisun ChemPharm Levodopa Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Xi'an Arisun ChemPharm Levodopa Product
Table 99. Xi'an Arisun ChemPharm Recent Development
Table . Hunan Nutramax Corporation Information
Table . Hunan Nutramax Description and Business Overview
Table . Hunan Nutramax Levodopa Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . Hunan Nutramax Levodopa Product
Table . Hunan Nutramax Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Levodopa Distributors List
Table 108. Levodopa Customers List
Table 109. Market Key Trends
Table 110. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 111. Key Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Levodopa Product Picture
Figure 2. Global Levodopa Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Levodopa Market Share by Application in 2020 & 2026
Figure 6. Pharmaceuticals Industry Examples
Figure 7. Dietary Supplements Examples
Figure 8. Global Levodopa Sales (MT) Growth Rate (2015-2026)
Figure 9. Global Levodopa Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Levodopa Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 11. Global Levodopa Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Levodopa Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Levodopa Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Levodopa Sales (MT) Growth Rate (2015-2026)
Figure 15. Europe Levodopa Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Levodopa Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Levodopa Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Levodopa Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Levodopa Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Levodopa Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Levodopa Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Levodopa Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Levodopa Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Levodopa Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Levodopa Players Market Share by Revenue in Levodopa 2015 & 2019
Figure 26. Levodopa Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Levodopa Revenue Share by Type (2015-2020)
Figure 28. Global Levodopa Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Levodopa Revenue Share by Application (2015-2020)
Figure 30. Global Levodopa Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Levodopa Sales Market Share by Type in 2019
Figure 32. United States Levodopa Sales Market Share by Type in 2019
Figure 33. Europe Levodopa Sales Market Share by Company in 2019
Figure 34. Europe Levodopa Sales Market Share by Type in 2019
Figure 35. Europe Levodopa Sales Market Share by Application in 2019
Figure 36. China Levodopa Sales Market Share by Company in 2019
Figure 37. China Levodopa Sales Market Share by Type in 2019
Figure 38. China Levodopa Sales Market Share by Application in 2019
Figure 39. Japan Levodopa Sales Market Share by Company in 2019
Figure 40. Japan Levodopa Sales Market Share by Type in 2019
Figure 41. Japan Levodopa Sales Market Share by Application in 2019
Figure 42. Southeast Asia Levodopa Sales Market Share by Company in 2019
Figure 43. Southeast Asia Levodopa Sales Market Share by Type in 2019
Figure 44. Southeast Asia Levodopa Sales Market Share by Application in 2019
Figure 45. India Levodopa Sales Market Share by Company in 2019
Figure 46. India Levodopa Sales Market Share by Type in 2019
Figure 47. India Levodopa Sales Market Share by Application in 2019
Figure 48. Xi'an Lyphar Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Hindustan Herbals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Xi'an ZB Biotech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Xi'an Arisun ChemPharm Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Hunan Nutramax Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Levodopa
Figure 55. Manufacturing Process Analysis of Levodopa
Figure 56. Levodopa Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Porter's Five Forces Analysis
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
パーキンソン病治療薬の世界市場レポート2020 Researchers are working to develop new and improved therapies for people with Parkinson's disease (PD). There have been many drugs that have been approved to treat Parkinson disease. Market Analysis and Insights: Global Parkinsons disease Drug Market Since the COVID-19 virus outbreak in December 201…- プロバイオティクスベース栄養補助食品の世界市場レポート2020 A recently published report by QY Research titled Global Probiotic-based Dietary Supplements Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically …
- 人間用栄養補助食品の世界市場レポート2020 Human Dietary Supplements can be taken orally by consumers who are unable to meet their nutritional needs through regular diet. Geographically, Asia-Pacific is the largest market for dietary supplements. Market Analysis and Insights: Global Human Dietary Supplements Market Since the COVID-19 virus o…
- 店頭販売（OTC）薬・栄養補助食品の世界市場レポート2020 Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They …
- L-カルニチンサプリメントの世界市場レポート2020 A recently published report by QY Research titled Global L-Carnitine Supplements Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides acc…